Tenofovir Disoproxil Fumarate Treatment for Pediatric Patients with Perinatally Acquired Chronic Hepatitis B

Journal Title: Gastro - Open Journal - Year 2015, Vol 1, Issue 4

Abstract

Objectives: Infection with Hepatitis B Virus (HBV) is an important cause of chronic liver disease in children. Perinatal transmission accounts for the majority of infections. We examined the effects of Tenofovir Disoproxil Fumarate (TDF) on pediatric patients with perinatally acquired Chronic Hepatitis B (CHB). Methods: We retrospectively analyzed the data on pediatric patients with perinatally acquired CHB treated with TDF over a 72-week period. Results: 55 cases were analyzed of which 26 were treated. Fourteen (54%) had immune active hepatitis and 12(46%) were in the immune tolerant phase. In both groups, no difference in inflammation or fibrosis was found on baseline liver biopsy. Mean HBV DNA level at baseline was 9 log10 copies/mL. Levels declined to 5.9 log10 copies/mL at 40 weeks of therapy and were undetectable in 19/26(73%) of the patients by week 72. Alanine aminotransferase (ALT) levels normalized by 32 weeks in the immune active hepatitis group. No breakthrough elevations were seen in either group. Overall, 11(42%) and 9(35%) of the patients had Hepatitis B e antigen (HBeAg) clearance and Hepatitis B e antibody (anti-HBe) seroconversion respectively by 72 weeks of treatment. Conclusion: TDF is an effective therapy in pediatric patients with perinatally acquired CHB in both immune active hepatitis and immune tolerant phase patients. Response to treatment did not seem to be affected by baseline ALT levels and liver histopathology findings.

Authors and Affiliations

Ricardo A. Arbizu

Keywords

Related Articles

Tenofovir Disoproxil Fumarate Treatment for Pediatric Patients with Perinatally Acquired Chronic Hepatitis B

Objectives: Infection with Hepatitis B Virus (HBV) is an important cause of chronic liver disease in children. Perinatal transmission accounts for the majority of infections. We examined the effects of Tenofovir Disoprox...

The Role of Pre-Assessment in Oesophageal Cancer Surgery

National figures for oesophagectomy mortality in the United Kingdom have been steadily dropping (12% to 9%) since the late 1990’s.1 More recently, these figures have improved significantly as shown in the 2016 annual re...

Effect of Chronic Proton Pump Inhibitor Use on Serum Magnesium Levels in Pediatric Patients

Hypomagnesemia has been reported in adult patients on Proton Pump Inhibitor (PPI) therapy. No studies have described the effect of this class on medications on Magnesium (Mg) levels in children. This was a retrospective...

Fistulizing Crohn’s Disease Complicated by Hidden Retroperitoneal Abscess: A Case Report and Review of the Literature

Crohn’s Disease (CD) is a chronic inflammatory disorder of the intestinal tract characterized by trans-mural damage of the bowel wall often complicated by strictures, entero-visceral and perianal fistulae and abscesses....

Gastric Diverticulum Misdiagnosed as a Left Adrenal Lesion

We report a case of gastric diverticulum misdiagnosed as a left adrenal lesion on both ultrasound and CT imaging and later identified on a follow-up CT. A 56 year-old man with a history of gastroesophageal reflux disease...

Download PDF file
  • EP ID EP555808
  • DOI 10.17140/GOJ-1-116
  • Views 160
  • Downloads 0

How To Cite

Ricardo A. Arbizu (2015). Tenofovir Disoproxil Fumarate Treatment for Pediatric Patients with Perinatally Acquired Chronic Hepatitis B. Gastro - Open Journal, 1(4), 94-99. https://europub.co.uk/articles/-A-555808